全文获取类型
收费全文 | 1499篇 |
免费 | 136篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 77篇 |
妇产科学 | 25篇 |
基础医学 | 135篇 |
口腔科学 | 58篇 |
临床医学 | 155篇 |
内科学 | 221篇 |
皮肤病学 | 21篇 |
神经病学 | 41篇 |
特种医学 | 286篇 |
外科学 | 84篇 |
综合类 | 41篇 |
一般理论 | 2篇 |
预防医学 | 142篇 |
眼科学 | 14篇 |
药学 | 170篇 |
肿瘤学 | 186篇 |
出版年
2021年 | 8篇 |
2020年 | 6篇 |
2019年 | 10篇 |
2018年 | 19篇 |
2017年 | 13篇 |
2016年 | 11篇 |
2015年 | 22篇 |
2014年 | 28篇 |
2013年 | 30篇 |
2012年 | 36篇 |
2011年 | 36篇 |
2010年 | 49篇 |
2009年 | 36篇 |
2008年 | 45篇 |
2007年 | 55篇 |
2006年 | 50篇 |
2005年 | 42篇 |
2004年 | 31篇 |
2003年 | 44篇 |
2002年 | 50篇 |
2001年 | 38篇 |
2000年 | 33篇 |
1999年 | 43篇 |
1998年 | 64篇 |
1997年 | 80篇 |
1996年 | 80篇 |
1995年 | 58篇 |
1994年 | 48篇 |
1993年 | 48篇 |
1992年 | 34篇 |
1991年 | 26篇 |
1990年 | 37篇 |
1989年 | 57篇 |
1988年 | 65篇 |
1987年 | 50篇 |
1986年 | 40篇 |
1985年 | 41篇 |
1984年 | 18篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 17篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1974年 | 9篇 |
1970年 | 8篇 |
1969年 | 8篇 |
排序方式: 共有1663条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
6.
7.
8.
Effect of pregnancy on the pharmacokinetics of metformin. 总被引:2,自引:0,他引:2
AIMS: To determine the effects of pregnancy on metformin pharmacokinetics. METHODS: Seven women with Type 2 diabetes mellitus taking metformin throughout pregnancy were studied on two occasions, once at 28-36 weeks gestation and once at least 8 weeks postpartum. Serum metformin concentrations were determined across a dosing interval using high-performance liquid chromatography. The areas under the serum concentration-time curve from 0 to 4 h post-dose (AUC0-4) and 0 to 8 h post-dose (AUC0-8) where possible, were compared in the pregnant and non-pregnant state. RESULTS: Metformin concentrations were lower in pregnancy in six subjects, with a mean (95% CI) AUC0-4 that was 69% (53.6, 84.8) of the postpartum value. The AUC0-4 of one subject was higher in pregnancy at 142% of the postpartum value. Overall, the mean (95% CI) AUC0-4 during pregnancy for all seven subjects was 80% (51.3, 107.8) of the postpartum value (P = 0.053, two-tailed t-test; P = 0.027, one-tailed t-test). CONCLUSION: These results are consistent with our hypothesis that the clearance of metformin increases in pregnancy as a result of enhanced renal elimination. A larger study is required to establish whether metformin dose adjustments are required in late pregnancy to maintain therapeutic effect. 相似文献
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献